Long-term preservation of biological samples is essential for reproducible research and future clinical use. Cryopreservation and biobanking support the continuity of regenerative medicine by storing viable cells, tissues, and bioengineered constructs without compromising their functionality. Innovations in cryoprotectants, controlled-rate freezing, and vitrification techniques now allow higher post-thaw survival rates and functionality of stem cells and engineered tissues. These advances are crucial for ensuring the availability of genetically matched materials for transplantation and personalized therapies. Cryopreservation and biobanking also play a central role in multi-center trials and biorepositories, enabling the sharing of standardized, quality-controlled samples. As demand increases for diverse and ethically sourced biospecimens, robust biobanking practices become a cornerstone of translational success in tissue engineering and regenerative medicine.
Title : Eliminating implants infections with nanomedicine: Human results
Thomas J Webster, Interstellar Therapeutics, United States
Title : Biodistribution and gene targeting in regenerative medicine
Nagy Habib, Imperial College London, United Kingdom
Title : Graphene, butterfly structures, and stem cells: A revolution in surgical implants
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, London NW1 0NH, United Kingdom
Title : Precision in cartilage repair: Breakthroughs in biofabrication process optimization
Pedro Morouco, Polytechnic of Leiria, Portugal
Title : Keratin-TMAO wound dressing promote tissue recovery in diabetic rats via activation of M2 macrophages
Marek Konop, Medical University of Warsaw, Poland
Title : Assessing geometric simplifications in vertebral modeling for reliable numerical analysis of intervertebral discs
Oleg Ardatov, Vilnius University, Lithuania